90 related articles for article (PubMed ID: 5971809)
1. [Distribution, metabolism and excretion of a new anti-inflammatory agent: p-butoxyphenyl-acethydroxamic acid (CP 1044 J3)].
Roncucci R; Simon MJ; Lambelin G; Buu-Hoï NP; Thiriaux J
Biochem Pharmacol; 1966 Oct; 15(10):1563-75. PubMed ID: 5971809
[No Abstract] [Full Text] [Related]
2. Intestinal absorption of p-butoxyphenylacethydroxamic acid and of p-butoxyphenylacetamide. In vitro studies on different segments of rat intestine.
Roncucci R; Simon MJ; Lambelin G; Gillet C; Thiriaux J; Buu-Hoï NP
Arch Int Pharmacodyn Ther; 1967 Jun; 167(2):260-4. PubMed ID: 6058775
[No Abstract] [Full Text] [Related]
3. Radiotracer distribution and excretion study of chlorophenothane in rats.
Bishara RH; Born GS; Christian JE
J Pharm Sci; 1972 Dec; 61(12):1912-6. PubMed ID: 4638097
[No Abstract] [Full Text] [Related]
4. Separation and identification of urinary metabolites of 14C-p-n-butoxyphenylacethydroxamic acid in man.
Roncucci R; Simon MJ; Lambelin G; Thiriaux J; Buu-Hoi NP
Biochem Pharmacol; 1968 Feb; 17(2):187-94. PubMed ID: 5647045
[No Abstract] [Full Text] [Related]
5. [Resorption, degradation and excretion of acetyldigoxin in animal experiments].
Buchtela K; Drexler K; Hackl H; Königstein M; Schläger J
Arzneimittelforschung; 1968 Mar; 18(3):295-303. PubMed ID: 5696004
[No Abstract] [Full Text] [Related]
6. Teratological studies of p-butoxyphenylacethydroxamic acid (CP 1044 J3) in rats and rabbits.
Roba J; Lambelin G; Buu-Hoï NP
Arzneimittelforschung; 1970 Apr; 20(4):565-9. PubMed ID: 5467822
[No Abstract] [Full Text] [Related]
7. The metabolism and distribution of the selective adrenergic beta blocking agent, practolol.
Scales B; Cosgrove MB
J Pharmacol Exp Ther; 1970 Nov; 175(2):338-47. PubMed ID: 4394800
[No Abstract] [Full Text] [Related]
8. Metabolism of aminonucleoside-8-14C in the rat and guinea pig.
Nagasawa HT; Swingle KF; Alexander CS
Biochem Pharmacol; 1967 Nov; 16(11):2211-9. PubMed ID: 6076611
[No Abstract] [Full Text] [Related]
9. [Studies on the pharmacokinetics and on the metabolism of 2(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride (St 155)].
Rehbinder D; Deckers W
Arzneimittelforschung; 1969 Feb; 19(2):169-76. PubMed ID: 5818753
[No Abstract] [Full Text] [Related]
10. [Studies with 14C-labelled noxiptilin. Metabolism and kinetics].
Duhm B; Maul W; Medenwald H; Patzschke K; Wegner L
Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:858+. PubMed ID: 5819765
[No Abstract] [Full Text] [Related]
11. Physiologic disposition of short chain aliphatic hydroxamates in the mouse. II. Absorption, distribution, metabolism and excretion of 1- 14C-acetohydroxamic acid.
Fishbein WN; Streeter CL; Daly J
J Pharmacol Exp Ther; 1973 Jul; 186(1):173-82. PubMed ID: 4723309
[No Abstract] [Full Text] [Related]
12. On the metabolic fate of gefarnate in rats.
Coppi G; Bonardi G; Martinelli E
Arzneimittelforschung; 1969 Sep; 19(9):1519-20. PubMed ID: 5394525
[No Abstract] [Full Text] [Related]
13. Identification of metabolites of phenylacetic acid in rat brain by plasma desorption mass spectrometry.
Loo YH; Miller KA; Nowlin J; Horning MG
Life Sci; 1980 Feb; 26(8):657-63. PubMed ID: 7382743
[No Abstract] [Full Text] [Related]
14. [On the question of the effect of tetracyclines on the content of catecholamines in the body of rabbits and rats].
Aleutskiĭ NN
Antibiotiki; 1969 Apr; 14(4):347-51. PubMed ID: 5795745
[No Abstract] [Full Text] [Related]
15. [Studies on the fate of the antidepressant amitriptyline in the organism of the rat and man].
Eschenhof E; Rieder J
Arzneimittelforschung; 1969 Jun; 19(6):957-66. PubMed ID: 5820041
[No Abstract] [Full Text] [Related]
16. Metabolic patterns of 4-allyloxy-3-chlorophenylacetic acid in rat, rabbit, dog, monkey, and man.
Roncucci R; Simon MJ; Lambelin G; Gillet C; Staquet M; Buu-Hoï NP
Arzneimittelforschung; 1970 May; 20(5):631-6. PubMed ID: 4987566
[No Abstract] [Full Text] [Related]
17. [Pharmacological study of p-butoxyphenylacethydroxamic acid (CP 1044 J3). II. Toxicological research].
Lambelin G; Buu-Hoi NP; Mees G; Thiriaux J; Huriaux M
Med Pharmacol Exp Int J Exp Med; 1966; 15(6):545-54. PubMed ID: 6013064
[No Abstract] [Full Text] [Related]
18. Biodegradations of the hydroxamic acid group of p-n-butoxyphenylacethydroxamic acid (bufexamac) in various animal species.
Roncucci R; Simon MJ; Lambelin G; Buu-Hoï NP
Xenobiotica; 1971; 1(4):567-8. PubMed ID: 5164808
[No Abstract] [Full Text] [Related]
19. Sustained release hormonal preparations. 9. Plasma levels and accumulation into various tissues of 6-methyl-17 alpha-acetoxy-4,6-pregnadiene-3,20-dione after oral administration or absorption from polydimethylsiloxane implants.
Kincl FA; Angee I; Chang CC; Rudel HW
Acta Endocrinol (Copenh); 1970 Jul; 64(3):508-18. PubMed ID: 4916445
[No Abstract] [Full Text] [Related]
20. The metabolism of 3-(2-acetoxyethyl)-5-methoxyindole(5-methoxytryptophol o-acetate).
Delvigs P; Taborsky RG
Biochem Pharmacol; 1967 Mar; 16(3):579-86. PubMed ID: 6034374
[No Abstract] [Full Text] [Related]
[Next] [New Search]
